rs541915908

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2

The NM_181840.1(KCNK18):​c.361dupT​(p.Tyr121LeufsTer44) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00143 in 1,613,916 control chromosomes in the GnomAD database, including 40 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00077 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 39 hom. )

Consequence

KCNK18
NM_181840.1 frameshift

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:3

Conservation

PhyloP100: 1.17

Publications

7 publications found
Variant links:
Genes affected
KCNK18 (HGNC:19439): (potassium two pore domain channel subfamily K member 18) Potassium channels play a role in many cellular processes including maintenance of the action potential, muscle contraction, hormone secretion, osmotic regulation, and ion flow. This gene encodes a member of the superfamily of potassium channel proteins containing two pore-forming P domains and the encoded protein functions as an outward rectifying potassium channel. A mutation in this gene has been found to be associated with migraine with aura.[provided by RefSeq, Jan 2011]
KCNK18 Gene-Disease associations (from GenCC):
  • migraine, with or without aura, susceptibility to, 13
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000775 (118/152258) while in subpopulation SAS AF = 0.0195 (94/4812). AF 95% confidence interval is 0.0163. There are 1 homozygotes in GnomAd4. There are 89 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 118 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNK18NM_181840.1 linkc.361dupT p.Tyr121LeufsTer44 frameshift_variant Exon 3 of 3 ENST00000334549.1 NP_862823.1 Q7Z418

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNK18ENST00000334549.1 linkc.361dupT p.Tyr121LeufsTer44 frameshift_variant Exon 3 of 3 1 NM_181840.1 ENSP00000334650.1 Q7Z418

Frequencies

GnomAD3 genomes
AF:
0.000762
AC:
116
AN:
152140
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00212
Gnomad SAS
AF:
0.0191
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00263
AC:
659
AN:
250950
AF XY:
0.00345
show subpopulations
Gnomad AFR exome
AF:
0.000186
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00239
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000882
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.00150
AC:
2188
AN:
1461658
Hom.:
39
Cov.:
33
AF XY:
0.00207
AC XY:
1506
AN XY:
727146
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33476
American (AMR)
AF:
0.000402
AC:
18
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00854
AC:
339
AN:
39700
South Asian (SAS)
AF:
0.0193
AC:
1667
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53392
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000450
AC:
50
AN:
1111820
Other (OTH)
AF:
0.00166
AC:
100
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
154
307
461
614
768
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000775
AC:
118
AN:
152258
Hom.:
1
Cov.:
32
AF XY:
0.00120
AC XY:
89
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41552
American (AMR)
AF:
0.000262
AC:
4
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00212
AC:
11
AN:
5184
South Asian (SAS)
AF:
0.0195
AC:
94
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68022
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000521
Hom.:
0
Bravo
AF:
0.000400
Asia WGS
AF:
0.0160
AC:
55
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Migraine, with or without aura, susceptibility to, 13 Pathogenic:1Uncertain:1Benign:1
Jun 14, 2022
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Mar 18, 2016
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:reference population

- -

May 21, 2020
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

A heterozygous duplication variant was identified, NM_181840.1(KCNK18):c.361dupT in exon 3 of 3 of the KCNK18 gene. This duplication is predicted to cause a frameshift from amino acid position 121 introducing a stop codon 44 residues downstream, NP_862823.1(KCNK18):p.(Tyr121Leufs*44), resulting in a truncated protein. The variant is present in the gnomAD population database at a frequency of 1.9% (561 heterozygotes, 11 homozygotes) in the South Asian subpopulation. It has been previously reported as likely pathogenic (ClinVar) and with questionable disease contribution (Gardiner, 2016). In addition, functional studies show that this variant produces a new isoform capable of repressing TREK1 and TREK2, however the mechanism of this activity is also questionable (Royal, P. et al. (2019)). There are no other downstream variants predicted to cause a truncated protein that have been reported as pathogenic in individuals with this condition (ClinVar). Based on information available at the time of curation, this variant has been classified as a VARIANT of UNCERTAIN SIGNIFICANCE (VUS). -

not provided Benign:2
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KCNK18: BS1, BS2 -

Apr 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.2
Mutation Taster
=138/62
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs541915908; hg19: chr10-118969015; COSMIC: COSV57972060; API